🔎 Trials Near Me

Početna › Prekomjerna tjelesna masa › Texas › Austin

Kliničke studije za Prekomjerna tjelesna masa u gradu Austin, TX

18 studija za Prekomjerna tjelesna masa traži sudionike na lokacijama u gradu Austin i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

U tijeku regrutacijaFaza 2
  • Elligo Clinical Research Center /ID# 282166, Austin
Od 18 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT07752979

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

U tijeku regrutacijaFaza 3
  • Texas Diabetes & Endocrinology, Austin
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

U tijeku regrutacijaFaza 3
  • IMA Clinical Research Austin, Austin
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

U tijeku regrutacijaFaza 3
  • Dell Children's Medical Center - PIN, Austin
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • IMA Clinical Research Austin, Austin
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

U tijeku regrutacijaFaza 3
  • FutureSearch Trials of Neurology, Austin
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

U tijeku regrutacijaFaza 3
  • Austin Heart, Austin
  • Velocity Clinical Research - Austin, Austin
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • IMA Clinical Research Austin, Austin
Od 18 do 75 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
  • The University of Texas at Austin, Austin
Od 18 do 75 godina · Oba spola · Ažurirano 21. ruj 2026. · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

U tijeku regrutacijaFaza 3
  • AURORA-1 Clinical Site, Austin
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

U tijeku regrutacijaFaza 3
  • AURORA-2 Clinical Site, Austin
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
  • ACCOMPLISH-2 Research Site, Austin
Od 18 do 79 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

U tijeku regrutacijaFaza 2
  • IMA Clinical Research Austin, Austin
Od 18 do 75 godina · Oba spola · Ažurirano 8. ruj 2026. · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

U tijeku regrutacijaFaza 3
  • Elligo Clinical Research Center, Austin
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

U tijeku regrutacijaFaza 3
  • Elligo Clinical Research Center, Austin
Od 18 do 99 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07684144

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

U tijeku regrutacijaFaza 3
  • ACCOMPLISH-1 Research Site, Austin
  • ACCOMPLISH-1 Research Site, Austin
Od 18 do 79 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07654361

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

U tijeku regrutacijaFaza 1
  • Elligo Clin Res Centre, Austin
Od 18 godina i više · Oba spola · Ažurirano 25. lip 2026. · NCT07607587

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

U tijeku regrutacijaFaza 1
  • Corxel Investigational Site, Austin
Od 18 do 55 godina · Žene · Ažurirano 17. lip 2026. · NCT07652047

Studije za Prekomjerna tjelesna masa u drugim gradovima

Ostale studije u gradu Austin

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.